Biostrand Revolutionizes Sequence Retrieval Via Nlp And Database Fusion

By Author: Orson Amiri
Total Articles: 397
Comment this article

ImmunoPrecise Antibodies Ltd.'s subsidiary, BioStrand®, released a pioneering white paper titled "New Paradigm for Biological Sequence Retrieval" on bioRχiv. It unveils HYFT-based methodology, revolutionizing biological sequence retrieval, surpassing BLAST. HYFT patterns act as unique signatures, unifying biological data. Parsing sequences retrieves HYFT patterns, indexing prioritizes comprehensive coverage. Benchmarking showed HYFT excels in higher identity matches, while BLAST in distant homologous sequences. Dirk Van Hyfte, Co-Founder of BioStrand, sees this as a significant contribution fostering collaboration in bioinformatics.

BioStrand introduced LENSai, a next-gen AI platform integrating a vast knowledge graph linking 25 billion relationships across 660 million data objects. This technology connects genes, proteins, structures, and pathways, revolutionizing drug discovery. Using ontology-driven NLP and AI-driven LLMs, BioStrand's approach combines LLM reasoning, knowledge graph semantics, and RAG models for biomedical data integration, exploration, and analysis, unlocking new possibilities in the field.

Read More - https://www.techdogs.com/tech-news/business-wire/biostrand-unveils-a-revolutionary-approach-to-biological-sequence-retrieval-a-fusion-of-natural-language-processing-and-database-research